The Evaluation and Treatment of Endocrine Forms of Hypertension

Alejandro Velasco, Wanpen Vongpatanasin

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Endocrine hypertension is an important secondary form of hypertension, identified in between 5% and 10% of general hypertensive population. Primary aldosteronism is the most common cause of endocrine hypertension, accounting for 1%–10% in uncomplicated hypertension and 7%–20% in resistant hypertension. Other less common causes of endocrine hypertension include Cushing syndrome, pheochromocytoma, thyroid disorders, and hyperparathyroidism. Diagnosis requires a high index of suspicion and the use of appropriate screening tests based on clinical presentation. Failure to make proper diagnosis may lead to catastrophic complications or irreversible hypertensive target organ damage. Accordingly, patients who are suspected to have endocrine hypertension should be referred to endocrinologists or hypertension specialists who are familiar with management of the specific endocrine disorders.

Original languageEnglish (US)
Article number528
JournalCurrent Cardiology Reports
Issue number9
StatePublished - Sep 1 2014
Externally publishedYes


  • Cushing syndrome
  • Endocrine forms of hypertension
  • Hyperparathyroidism
  • Hyperthyroidism
  • Hypothyroidism
  • Pheochromocytoma
  • Primary aldosteronism
  • Secondary hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The Evaluation and Treatment of Endocrine Forms of Hypertension'. Together they form a unique fingerprint.

Cite this